US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.797
  • +0.217+8.41%
Close Dec 26 16:00 ET
32.28MMarket Cap-13.91P/E (TTM)

CytoMed Therapeutics Key Stats

EPS
According to the latest financial report of CytoMed Therapeutics, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: SGD

Quarterly

Loading...

FCF
Interested in knowing about CytoMed Therapeutics's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: SGD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CytoMed Therapeutics shows that the company's current ratio is 21.53, indicating healthy liquidity.

Currency: SGD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CytoMed Therapeutics, the quick ratio is 18.22, indicating that the company can meet its short-term debt obligations.

Currency: SGD

Quarterly

Loading...

ROE
Want to learn more about the financial health of CytoMed Therapeutics? The latest ROE figure is --, indicating that the company has stable profitability.

Currency: SGD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CytoMed Therapeutics, the total asset return on investment (ROA) is --.

Currency: SGD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check CytoMed Therapeutics's latest financial report to see how their gross margin is doing - currently at --.

Currency: SGD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CytoMed Therapeutics, the net profit margin is --, which is a good sign for its profitability.

Currency: SGD

Quarterly

Loading...

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.